ANAVO_CARE_(BRAMPTON)_LIM - Accounts


Company registration number 13858192 (England and Wales)
ANAVO CARE (BRAMPTON) LIMITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
ANAVO CARE (BRAMPTON) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 8
ANAVO CARE (BRAMPTON) LIMITED
BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 1 -
2023
Notes
£
£
Fixed assets
Tangible assets
5
21,996
Current assets
Stocks
4,870
Debtors
6
161,785
Cash at bank and in hand
386,666
553,321
Creditors: amounts falling due within one year
7
(912,566)
Net current liabilities
(359,245)
Total assets less current liabilities
(337,249)
Creditors: amounts falling due after more than one year
8
(104,500)
Provisions for liabilities
(5,871)
Net liabilities
(447,620)
Capital and reserves
Called up share capital
9
1
Profit and loss reserves
(447,621)
Total equity
(447,620)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 March 2024 and are signed on its behalf by:
Mr J O Braganza
Director
Company registration number 13858192 (England and Wales)
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023
- 2 -
1
Accounting policies
Company information

Anavo Care (Brampton) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Heston Court Business Centre, 19 Camp Road, Wimbeldon, SW19 4UW.

1.1
Reporting period

The financial statements was for a longer period 19th January 2022 to 31st March 2023 being the company's first year of incorporation.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.

1.3
Going concern

The directors have considered the appropriateness of the going concern basis in preparing the financial statements of the company for the period ending 31 March 2023. The company's immediate parent undertaking, has agreed to provide continuing financial support to the company, for at least twelve months after the date of approval by the directors of the financial statements for the period ended 31 March 2023. To enable the company to meet its liabilities as they fall due and as such the directors believe that the company is well placed to manage its business risks successfully. Thus the directors continue to adopt the going concern basis in preparing the financial statements.true

1.4
Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

 

Revenue is recognised on a time-elapsed basis as the principal performance obligation is to provide bed capacity. Units of care under these contracts are typically provided on a daily basis for customers for the provision of care and support services and providing activities organised by the company

 

 

1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is five years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 3 -
1.6
Tangible fixed assets

Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
5 years on cost
Computers
3 years on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 4 -
1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.15
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
- 6 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2023
Number
Total
52
4
Intangible fixed assets
Goodwill
£
Cost
At 19 January 2022
-
0
Additions
11
At 31 March 2023
11
Amortisation and impairment
At 19 January 2022
-
0
Impairment losses
11
At 31 March 2023
11
Carrying amount
At 31 March 2023
-
0
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 19 January 2022
-
0
Additions
24,400
At 31 March 2023
24,400
Depreciation and impairment
At 19 January 2022
-
0
Depreciation charged in the period
2,404
At 31 March 2023
2,404
Carrying amount
At 31 March 2023
21,996
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
- 7 -
6
Debtors
2023
Amounts falling due within one year:
£
Trade debtors
90,940
Other debtors
70,845
161,785
7
Creditors: amounts falling due within one year
2023
£
Trade creditors
91,953
Taxation and social security
25,495
Other creditors
795,118
912,566
8
Creditors: amounts falling due after more than one year
2023
£
Other creditors
104,500

Included in other creditors are loans of £104,500, which are secured by fixed and floating charges over the assets of the company.

9
Called up share capital
2023
2023
Ordinary share capital
Number
£
Issued and fully paid
Ordinary of £1 each
1
1
10
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Bobby Gurdep Bhogal ACA ACCA ATT
Statutory Auditor:
Arnold Hill & Co LLP
Date of audit report:
8 March 2024
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2023
- 8 -
11
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases relating to the leased property, as follows:

2023
£
Within one year
1,158,047
Between two and five years
4,632,187
In over five years
33,583,357
39,373,591
12
Related party transactions
Transactions with related parties

At the balance sheet date, included within other creditors, Anavo Care (Brampton) Ltd owed £50,000 to Anavo Care Ltd, the immediate parent company.

13
Parent company

The immediate parent company is Anavo Care Ltd, a company incorporated in England and Wales.

2023-03-312022-01-19false08 March 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityThis audit opinion is unqualifiedJames Oliver BRAGANZAThomas Allan BROOKESEdward Guy MOOREfalse138581922022-01-192023-03-31138581922023-03-3113858192core:OtherPropertyPlantEquipment2023-03-3113858192core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3113858192core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-3113858192core:CurrentFinancialInstruments2023-03-3113858192core:ShareCapital2023-03-3113858192core:RetainedEarningsAccumulatedLosses2023-03-3113858192bus:Director12022-01-192023-03-3113858192core:Goodwill2022-01-192023-03-3113858192core:FurnitureFittings2022-01-192023-03-3113858192core:ComputerEquipment2022-01-192023-03-3113858192core:NetGoodwill2022-01-1813858192core:NetGoodwill2023-03-3113858192core:NetGoodwill2022-01-192023-03-3113858192core:OtherPropertyPlantEquipment2022-01-1813858192core:OtherPropertyPlantEquipment2022-01-192023-03-3113858192core:WithinOneYear2023-03-3113858192core:Non-currentFinancialInstruments2023-03-3113858192core:BetweenTwoFiveYears2023-03-3113858192core:MoreThanFiveYears2023-03-3113858192bus:PrivateLimitedCompanyLtd2022-01-192023-03-3113858192bus:SmallCompaniesRegimeForAccounts2022-01-192023-03-3113858192bus:FRS1022022-01-192023-03-3113858192bus:Audited2022-01-192023-03-3113858192bus:Director22022-01-192023-03-3113858192bus:Director32022-01-192023-03-3113858192bus:FullAccounts2022-01-192023-03-31xbrli:purexbrli:sharesiso4217:GBP